Loading insider details...
Latest Form 4 (Jun 10, 2026): Sale of 6,400 ABOS shares, $14.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale | 6,400 | $14.3K |
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| Jun 5, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 12,800 | n/a |
| Jun 10, 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 7, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 17, 2022 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jul 8, 2021 | Acumen Pharmaceuticals, Inc. (ABOS) | Purchase | 6,250 | $100.0K |
| Jul 2, 2021 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 34,000 | n/a |